David Kirske

Chief Financial Officer

Chief Financial Officer at X4 Pharmaceuticals, Inc, filing insider transactions between 2026-06-30 and 2026-10-01.

Total Purchases

—

0 transactions

Total Sales

$70K

2 transactions

Companies Traded

2 total filings

Active Since

2026-06-30

Last: 2026-10-01

Companies

X4 Pharmaceuticals, Inc

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-10-01	XFOR	Sale	11.8K	$2.86	$34K	156.0K	SEC ↗
2026-06-30	XFOR	Sale	8,543	$4.26	$36K	167.8K	SEC ↗